Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

MESO

Mesoblast Limited

Healthcare · USD

Set alert

Price alert · MESO

All alert types
15.16 USD -0.51 -3.25%
As of Oct 30, 2026 Extended hours 15.30 +0.92%
Bid
15.12 × 2
Ask
15.15 × 2
14.84 Day range 15.69
11.95 52-week range 20.96
YTD
-15.96%
1 year
-7.73%
Open
15.38
Prev close
15.67
Mkt cap
1.97B
Vol
375.99K
Avg vol
231.76K
EPS
-0.44
P/E
0.00
Div yield
0.00%
More statistics
Low
14.84
High
15.69
Forward P/E
33.32
Beta
0.86
Short ratio
14.11
Inst. own
3.27%
Dividend
0.00
Ex-div date
Earnings
Mar 4, 2027
50-d avg
14.98
200-d avg
15.42
1y target
37.00

5D chart

Chart tools
Interval
1m5m15m30m
MESO five-day price chart12.313.214.114.915.8Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

3.92 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -30.1×
FY 2017: -11.4×FY 2018: -14.5×FY 2019: -5.6×FY 2020: -15.2×FY 2021: -9.4×FY 2022: -3.4×FY 2023: -8.0×FY 2024: -7.6×FY 2025: -12.9×FY 2026: -30.1×
FY 2017 5y median -8.0× FY 2026
P/S 14.5×
FY 2017: 354×FY 2018: 29.5×FY 2019: 29.9×FY 2020: 37.5×FY 2021: 121×FY 2022: 29.7×FY 2023: 87.3×FY 2024: 113×FY 2025: 76.5×FY 2026: 14.5×
FY 2017 5y median 76.5× FY 2026
P/B 3.1×
FY 2017: 1.7×FY 2018: 0.9×FY 2019: 1.0×FY 2020: 2.2×FY 2021: 1.6×FY 2022: 0.6×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 2.2×FY 2026: 3.1×
FY 2017 5y median 1.4× FY 2026
P/FCF -39.2×
FY 2017: -8.9×FY 2018: -6.8×FY 2019: -8.6×FY 2020: -20.6×FY 2021: -8.4×FY 2022: -4.6×FY 2023: -10.3×FY 2024: -13.7×FY 2025: -26.0×FY 2026: -39.2×
FY 2017 5y median -13.7× FY 2026
EV/EBITDA -42.7×
FY 2017: -9.3×FY 2018: -7.1×FY 2019: -6.3×FY 2020: -17.0×FY 2021: -10.3×FY 2022: -4.6×FY 2023: -12.0×FY 2024: -13.6×FY 2025: -17.4×FY 2026: -42.7×
FY 2017 5y median -13.6× FY 2026
EV/Sales 15.2×
FY 2017: 335×FY 2018: 30.8×FY 2019: 31.7×FY 2020: 36.5×FY 2021: 117×FY 2022: 34.3×FY 2023: 93.4×FY 2024: 123×FY 2025: 74.6×FY 2026: 15.2×
FY 2017 5y median 74.6× FY 2026
FCF Yield -2.6%
FY 2017: -11.2%FY 2018: -14.7%FY 2019: -11.6%FY 2020: -4.9%FY 2021: -12.0%FY 2022: -21.8%FY 2023: -9.7%FY 2024: -7.3%FY 2025: -3.9%FY 2026: -2.6%
FY 2017 5y median -7.3% FY 2026

Profitability

Gross Margin 84.1%
FY 2017: -400.2%FY 2018: 68.2%FY 2019: -349.5%FY 2020: -153.4%FY 2021: -1049.8%FY 2022: -522.6%FY 2023: -632.2%FY 2024: -595.9%FY 2025: 70.2%FY 2026: 84.1%
FY 2017 5y median -522.6% FY 2026
Operating Margin -42.6%
FY 2017: -3733.1%FY 2018: -446.0%FY 2019: -479.6%FY 2020: -232.8%FY 2021: -1463.2%FY 2022: -789.1%FY 2023: -923.7%FY 2024: -1425.7%FY 2025: -363.1%FY 2026: -42.6%
FY 2017 5y median -789.1% FY 2026
Net Margin -47.8%
FY 2017: -3184.7%FY 2018: -203.5%FY 2019: -537.0%FY 2020: -242.4%FY 2021: -1325.3%FY 2022: -894.6%FY 2023: -1091.7%FY 2024: -1490.3%FY 2025: -593.9%FY 2026: -47.8%
FY 2017 5y median -894.6% FY 2026
ROE -10.2%
FY 2017: -14.9%FY 2018: -6.5%FY 2019: -18.7%FY 2020: -14.2%FY 2021: -17.0%FY 2022: -18.4%FY 2023: -16.3%FY 2024: -18.3%FY 2025: -17.1%FY 2026: -10.2%
FY 2017 5y median -17.1% FY 2026
ROIC -7.3%
FY 2017: -12.4%FY 2018: -6.2%FY 2019: -11.7%FY 2020: -9.8%FY 2021: -15.3%FY 2022: -13.0%FY 2023: -10.8%FY 2024: -13.7%FY 2025: -8.5%FY 2026: -7.3%
FY 2017 5y median -10.8% FY 2026
ROA -7.5%
FY 2017: -11.7%FY 2018: -5.1%FY 2019: -13.8%FY 2020: -10.6%FY 2021: -13.3%FY 2022: -13.8%FY 2023: -12.2%FY 2024: -13.1%FY 2025: -13.0%FY 2026: -7.5%
FY 2017 5y median -13.0% FY 2026

Growth (YoY)

Revenue 602.3%
FY 2017: -94.3%FY 2018: 618.9%FY 2019: -3.6%FY 2020: 92.3%FY 2021: -76.8%FY 2022: 37.0%FY 2023: -26.5%FY 2024: -21.3%FY 2025: 191.4%FY 2026: 602.3%
FY 2017 FY 2026
Operating Income 17.5%
FY 2017: -61.1%FY 2018: 14.1%FY 2019: -3.7%FY 2020: 6.6%FY 2021: -45.7%FY 2022: 26.1%FY 2023: 14.0%FY 2024: -21.4%FY 2025: 25.8%FY 2026: 17.5%
FY 2017 FY 2026
EPS (diluted) 46.7%
FY 2017: -1718.2%FY 2018: 45.9%FY 2019: -137.5%FY 2020: 16.7%FY 2021: -6.7%FY 2022: 18.8%FY 2023: 24.9%FY 2024: 8.7%FY 2025: 5.3%FY 2026: 46.7%
FY 2017 FY 2026
Free Cash Flow 11.8%
FY 2017: -7.7%FY 2018: 21.5%FY 2019: 22.8%FY 2020: -0.9%FY 2021: -84.8%FY 2022: 39.1%FY 2023: 3.7%FY 2024: 23.3%FY 2025: -3.9%FY 2026: 11.8%
FY 2017 FY 2026

Financial Health

Current Ratio 2.4×
FY 2017: 1.7×FY 2018: 4.2×FY 2019: 1.4×FY 2020: 1.5×FY 2021: 1.6×FY 2022: 1.4×FY 2023: 1.9×FY 2024: 1.2×FY 2025: 2.0×FY 2026: 2.4×
FY 2017 5y median 1.9× FY 2026
Quick Ratio 2.1×
FY 2017: 1.4×FY 2018: 6.0×FY 2019: 1.4×FY 2020: 1.5×FY 2021: 1.6×FY 2022: 1.4×FY 2023: 1.9×FY 2024: 1.2×FY 2025: 1.8×FY 2026: 2.1×
FY 2017 5y median 1.8× FY 2026
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×FY 2026: 0.2×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA -1.9×
FY 2017: 0.5×FY 2018: -0.3×FY 2019: -0.4×FY 2020: 0.4×FY 2021: 0.4×FY 2022: -0.6×FY 2023: -0.8×FY 2024: -1.1×FY 2025: 0.4×FY 2026: -1.9×
FY 2017 5y median -0.8× FY 2026
Interest Coverage -2.2×
FY 2017: 0.0×FY 2018: -42.3×FY 2019: -6.9×FY 2020: -5.1×FY 2021: -10.2×FY 2022: -4.7×FY 2023: -3.6×FY 2024: -4.1×FY 2025: -2.7×FY 2026: -2.2×
FY 2017 5y median -3.6× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30